143 related articles for article (PubMed ID: 24923911)
1. Comment on Ma XL et al.: prognostic role of circulating tumor cells and disseminated tumor cells in patients with prostate cancer: a systematic review and meta-analysis.
Xia Q; Liu C; He S; Wang B
Tumour Biol; 2014 Aug; 35(8):7403-4. PubMed ID: 24923911
[No Abstract] [Full Text] [Related]
2. Prognostic role of circulating tumor cells and disseminated tumor cells in patients with prostate cancer: a systematic review and meta-analysis.
Ma X; Xiao Z; Li X; Wang F; Zhang J; Zhou R; Wang J; Liu L
Tumour Biol; 2014 Jun; 35(6):5551-60. PubMed ID: 24563278
[TBL] [Abstract][Full Text] [Related]
3. Detection and characterization of circulating and disseminated prostate cancer cells.
Morgan TM; Lange PH; Vessella RL
Front Biosci; 2007 May; 12():3000-9. PubMed ID: 17485277
[TBL] [Abstract][Full Text] [Related]
4. Role of transurethral resection of the prostate in hematogenously disseminated metastasis.
Bhatti R; Baumgartner G; Guinan P; Ray P; McKiel C
Urol Int; 1988; 43(1):29-31. PubMed ID: 3376360
[TBL] [Abstract][Full Text] [Related]
5. Circulating Tumor Cells: A Reliable Biomarker for Prostate Cancer Treatment Assessment?
Ciccarese C; Montironi R; Fiorentino M; Martignoni G; Brunelli M; Iacovelli R; Lopez-Beltran A; Cheng L; Scarpelli M; Moch H; Tortora G; Massari F
Curr Drug Metab; 2017; 18(8):692-699. PubMed ID: 28524006
[TBL] [Abstract][Full Text] [Related]
6. Disseminated tumor cells and dormancy in prostate cancer metastasis.
van der Toom EE; Verdone JE; Pienta KJ
Curr Opin Biotechnol; 2016 Aug; 40():9-15. PubMed ID: 26900985
[TBL] [Abstract][Full Text] [Related]
7. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
[TBL] [Abstract][Full Text] [Related]
8. Comment on Han L et al.: prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis.
Li C; Zhao Z; Liu R
Tumour Biol; 2014 Sep; 35(9):8353-4. PubMed ID: 25172098
[No Abstract] [Full Text] [Related]
9. Prognostic significance of circulating tumor cells in patients with hormone refractory prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2009 Mar; 181(3):1091-7. PubMed ID: 19150091
[TBL] [Abstract][Full Text] [Related]
10. Dramatically elevated circulating tumor cell numbers in a patient with small cell neuroendocrine carcinoma of the prostate.
Chan F; Goodman O; Fink L; Vogelzang NJ; Pomerantz D; Khoury JD
Arch Pathol Lab Med; 2010 Jan; 134(1):120-3. PubMed ID: 20073615
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumor cells in prostate cancer: beyond enumeration.
Chen JF; Lu YT; Cheng S; Tseng HR; Figlin RA; Posadas EM
Clin Adv Hematol Oncol; 2017 Jan; 15(1):63-73. PubMed ID: 28212371
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor cells in peripheral blood samples from patients with increased serum prostate specific antigen: initial results in early prostate cancer.
Davis JW; Nakanishi H; Kumar VS; Bhadkamkar VA; McCormack R; Fritsche HA; Handy B; Gornet T; Babaian RJ
J Urol; 2008 Jun; 179(6):2187-91; discussion 2191. PubMed ID: 18423725
[TBL] [Abstract][Full Text] [Related]
13. The current role of circulating tumor cells in the diagnosis and management of bone metastases in advanced prostate cancer.
Saad F; Pantel K
Future Oncol; 2012 Mar; 8(3):321-31. PubMed ID: 22409467
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of circulating tumor cells as a survival predictor in metastatic castration-resistant prostate cancer: missing parts in a superb study.
Glinsky GV
Clin Cancer Res; 2009 Feb; 15(4):1504; 1504-5. PubMed ID: 19228753
[No Abstract] [Full Text] [Related]
15. Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases.
Thiounn N; Saporta F; Flam TA; Pages F; Zerbib M; Vieillefond A; Martin E; Debré B; Chevillard S
Urology; 1997 Aug; 50(2):245-50. PubMed ID: 9255296
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of disseminated tumor cells in the bone marrow of prostate cancer patients treated with neoadjuvant hormone treatment.
Köllermann J; Weikert S; Schostak M; Kempkensteffen C; Kleinschmidt K; Rau T; Pantel K
J Clin Oncol; 2008 Oct; 26(30):4928-33. PubMed ID: 18794550
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor cells in prostate cancer: a better predictor of survival than prostate specific antigen?
Hu B; Goldkorn A
Expert Rev Anticancer Ther; 2014 Nov; 14(11):1257-60. PubMed ID: 25199875
[TBL] [Abstract][Full Text] [Related]
18. Research Progress for the Clinical Application of Circulating Tumor Cells in Prostate Cancer Diagnosis and Treatment.
Yang M; Zhang X; Guo L; Liu X; Wu J; Zhu H
Biomed Res Int; 2021; 2021():6230826. PubMed ID: 33506020
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor cells in prostate cancer: Does (nuclear) size matter?
Pal SK; Agarwal N; Jones JO
Cancer; 2015 Sep; 121(18):3190-2. PubMed ID: 25980931
[No Abstract] [Full Text] [Related]
20. Association between Postoperative Detection of Circulating Tumor Cells and Recurrence in Patients with Prostate Cancer.
Pak S; Suh YS; Lee DE; Kim SH; Joung JY; Park WS; Lee SJ; Lee KH
J Urol; 2020 Jun; 203(6):1128-1134. PubMed ID: 31845840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
